Open menu
Nanowerk

Nanotechnology Business News

The latest product and company news

RSS Subscribe to our Nanotechnology Business News feed

Access Pharmaceuticals Signs Agreement With Major Global Pharmaceutical Company for RNAi Therapeutic Delivery Technologies

Access Pharmaceuticals, Inc., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has entered into an agreement with a major pharmaceutical company to exploit its CobaCyte and CobOral technology for the targeted delivery of RNAi therapeutics.

Posted: Apr 13th, 2011

Read more